Source link : https://www.newshealth.biz/health-news/semaglutide-2-4-mg-reduces-all-cause-hospital-admissions/
SAN ANTONIO — Treatment with once-weekly semaglutide 2.4 mg (Wegovy) significantly reduced hospital admissions for all causes — not just cardiac — and overall hospitalization time in people with overweight/obesity and established cardiovascular disease (CVD). The new findings come from prespecified analyses of Novo-Nordisk’s multicenter, randomized SELECT trial, which showed that compared with placebo, weekly […]
Author : News Health
Publish date : 2024-11-04 13:03:53
Copyright for syndicated content belongs to the linked Source.